Related Experiment Video
Updated: Dec 4, 2025

Identification of Kinase-substrate Pairs Using High Throughput Screening
Published on: August 29, 2015
A Screen for PKN3 Substrates Reveals an Activating Phosphorylation of ARHGAP18
Michal Dibus1,2, Jan Brábek1,2, Daniel Rösel1,2
1Department of Cell Biology, Charles University, Viničná 7, 12800 Prague, Czech Republic.
Abstract:
Protein kinase N3 (PKN3) is a serine/threonine kinase implicated in tumor progression of multiple cancer types, however, its substrates and effector proteins still remain largely understudied. In the present work we aimed to identify novel PKN3 substrates in a phosphoproteomic screen using analog sensitive PKN3. Among the identified putative substrates we selected ARHGAP18, a protein from RhoGAP family, for validation of the screen and further study. We confirmed that PKN3 can phosphorylate ARHGAP18 in vitro and we also characterized the interaction of the two proteins, which is mediated via the N-terminal part of ARHGAP18. We present strong evidence that PKN3-ARHGAP18 interaction is increased upon ARHGAP18 phosphorylation and that the phosphorylation of ARHGAP18 by PKN3 enhances its GAP domain activity and contributes to negative regulation of active RhoA. Taken together, we identified new set of potential PKN3 substrates and revealed a new negative feedback regulatory mechanism of Rho signaling mediated by PKN3-induced ARHGAP18 activation.
Insights
Researchers identified new protein kinase N3 (PKN3) substrates, revealing a feedback loop where PKN3 activates ARHGAP18 to regulate RhoA signaling, crucial for understanding cancer progression.
Area of Science:
- Molecular Biology
- Cell Signaling
- Cancer Research
Background:
- Protein kinase N3 (PKN3) is a serine/threonine kinase involved in tumor progression.
- PKN3's substrates and effector proteins are not well understood, limiting therapeutic target identification.
Purpose of the Study:
- To identify novel substrates of PKN3 using phosphoproteomic screening.
- To investigate the functional relationship between PKN3 and its newly identified substrate, ARHGAP18.
Main Methods:
- Utilized analog-sensitive PKN3 for phosphoproteomic screening.
- Performed in vitro kinase assays to validate PKN3-ARHGAP18 interaction and phosphorylation.
- Assessed the impact of PKN3-mediated phosphorylation on ARHGAP18's Rho GTPase-activating protein (GAP) activity.
Main Results:
- Identified ARHGAP18 as a novel substrate of PKN3.
- Confirmed direct phosphorylation of ARHGAP18 by PKN3 in vitro, with interaction mediated by ARHGAP18's N-terminal region.
- Demonstrated that PKN3 phosphorylation enhances ARHGAP18's GAP activity, leading to negative regulation of active RhoA.
Conclusions:
- Discovered a new set of potential PKN3 substrates.
- Elucidated a novel negative feedback mechanism in Rho signaling involving PKN3-induced activation of ARHGAP18.
- This finding offers insights into cancer progression pathways regulated by PKN3 and RhoA.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
MAPK Signaling Cascades
cAMP-dependent Protein Kinase Pathways
The JAK-STAT Signaling Pathway
Amplifying Signals via Enzymatic Cascade

